What works, and what remains to be done, in HIV prevention in the United States

Annual Review of Public Health

Volumn 27, Issue , 2006, Pages 261-275

  Holtgrave, David R ^a   Curran, James W ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; FUNDING; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INVESTMENT; LIMB REPLANTATION; OUTCOME ASSESSMENT; PREVENTIVE HEALTH SERVICE; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SEXUAL BEHAVIOR; SOCIETY; UNITED STATES; VIRUS TRANSMISSION;

COST-BENEFIT ANALYSIS; FINANCING, GOVERNMENT; HEALTH POLICY; HIV INFECTIONS; HUMANS; ORGANIZATIONAL OBJECTIVES; PREVENTIVE HEALTH SERVICES; RESEARCH; UNITED STATES;

EID: 33645812933     PISSN: 01637525     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.publhealth.26.021304.144454     Document Type: Review

References (57)

1. Am. Civil Liberties Union. 2003. HIV & Civil Rights: A report from the frontlines of the HIV/AIDS epidemic. Washington, DC: ACLU
2. Am. Med. Assoc., Am. Pharm. Assoc., Assoc. State Territ. Health Off., Natl. Assoc. Boards Pharm., Natl. Alliance State Territ. AIDS Dir. Oct. 1999. HIV prevention & access to sterile syringes. http://www.nastad.org/ PublicPolicyResources/HIVPrevSterileSyrines.pdf
3. Ashman JJ, Conviser R, Pounds M. 2002. Associations between HIV-positive individuals' receipt of ancillary services and medical care receipt and retention. AIDS Care 14(Suppl. 1):S109-18
4. Brookmeyer R. 1991. Reconstruction and future trends of the AIDS epidemic in the United States. Science 253:37-42
5. Cent. Dis. Control. 1993. HIV/AIDS. Surveillance Report: U.S. HIV and AIDS cases reported through December 1993 (Year-end edition). 5(4):Table 13
6. Cent. Dis. Control. 1999. Compendium of HIV Prevention Interventions with Evidence of Effectiveness. Atlanta, GA: CDC, Nov. (revised)
7. Cent. Dis. Control. 2001. HIV Prevention Strategic Plan Through 2005. Atlanta, GA: CDC
8. Cent. Dis. Control. 2001. HIV/AIDS Surveillance Report: U.S. HIV and AIDS cases reported through December 2001 (Year-end edition). 13(2):Table 33
9. Cent. Dis. Control. 2002. A glance at the HIV epidemic. http://www.cdc.gov/hiv/publs.facts.htm
10. Cent. Dis. Control. 2002. HIV/AIDS Surveillance Report: U.S. Cases of HIV and AIDS in the United States, 2002 (Year-end edition). 14:Table 7
11. Cent. Dis. Control. 2003. Advancing HIV Prevention: new strategies for a changing epidemic-United States, 2003. MMWR 52:329-32
12. Cent. Dis. Control. 2004. Advancing HIV Prevention: Progress fact sheet. http://www.cdc.gov/hiv/partners/AHP/progress facts.htm on 6/30/2004
13. Cent. Dis. Control. 2004. Advancing HIV Prevention: The science behind the new initiative. http://www.cdc.gov/hiv/partners/ahp_science.htm on 6/30/2004
14. Cent. Dis. Control. 2004. Status of perinatal HIV prevention: U.S. declines continue. http://www.cdc.gov/hiv/pubs/facts/perinatl.htm on 9/14/2004
15. Cent. Dis. Control. 2004. Young people at risk: HIV/AIDS among America's youth. http://www.cdc.gov/hiv/pubs/facts/youth.htm on 9/14/2004
16. Cohen DA, Wu SY, Farley TA. A cost effective national strategy for preventing HIV transmission across the United States. Int. Conf. AIDS, 15th, Bangkok, Thailand. Abstr. TuPeC4931
17. Comm. Public Financ. Deliv. HIV Care. 2004. Public Financing and Delivery of HIV/AIDS Care: Securing the Legacy of Ryan White. Washington, DC: Inst. Med., Natl. Acad. Press
18. Collins CB, Harschbarger C, Sawyer R. 2004. Broad diffusion of twelve effective behavioral interventions for HIV prevention. Int. Conf. AIDS, 15th, Bangkok, Thailand. Abst. ThPeE8182
19. Curran JW. 2003. Reflections on AIDS, 1981-2031. Am. J. Prev. Med. 24:281-84
20. Des Jarlais DC, Semaan S. HIV prevention research: cumulative knowledge or accumulating studies? An introduction to the HIV/AIDS Prevention Research Synthesis Project Supplement. J. AIDS 30(Suppl. 1):S1-7
21. Fleming PL, Byers RH, Sweeney PA, Daniels D, Karon JM, Janssen RS. 2002. HIV prevalence in the United States, 2000. Presented at Conf. Retroviruses and Opportunistic Infections, 9th. http://www.retroconference.org/2002/Abstract/ 13996.htm
22. Global HIV Prev. Work. Group. 2004. HIV Prevention in the Era of Expanded Treatment Access. Seattle: Bill & Melinda Gates Found.
23. Holtgrave DR. 2006. Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both? Int. J. STD AIDS. In press
24. Holtgrave DR. 2006. Determining the intensity of prevention interventions for persons living with HIV: an application of economic threshold analysis. AIDS. In press
25. Holtgrave DR. 2005. A proposed format for tracking CDC's National HIV Prevention Goal. J. Public Health Manage. Pract. 11(1):4-6
26. Holtgrave DR. 2004. Estimation of annual HIV transmission rates in the United States, 1978-2000. J. AIDS 35(1):89-92
27. Holtgrave DR. 2004. HIV prevention, cost-utility analysis, and race/ethnicity: Methodological considerations and recommendations. Med. Decision Making 24(2):181-91
28. Holtgrave DR. 2003. Science, values and the public health agencies. AIDS Educ. Prev. 15:203-4.
29. Holtgrave DR. 2002. Estimating the effectiveness and efficiency of HIV prevention efforts in the U.S. using scenario and cost-effectiveness analysis. AIDS 16:2347-49
30. Holtgrave DR. 2002. A framework for gauging the comprehensiveness of governmental HIV prevention programs. J. Public Health Manage. Pract. 8:22-29
31. Holtgrave DR, ed. 1998. Handbook of Economic Evaluation of HIV Prevention Programs. New York: Plenum
32. Holtgrave DR, Anderson T. 2004. Utilizing HIV transmission rates to assist in prioritizing HIV prevention services. Int. J. STD. AIDS 15(12)789-92
33. Holtgrave DR, Kelly JA. 1996. Preventing HIV/AIDS among high-risk urban women: the cost-effectiveness of a behavioral group intervention. Am. J. Public Health 86:1442-45
34. Holtgrave DR, Pinkerton SD. 2003. Economic implications of failure to reduce incident HIV infections by 50% by 2005 in the United States. J. AIDS 33(2):171-74
35. Holtgrave DR, Pinkerton SD. 2002. Implications of economic evaluation for national HIV prevention policy makers. In Quantitative Evaluation of HIV Prevention Programs, ed. EH Kaplan, R Brookmeyer, pp. 32-54. New Haven, CT: Yale Univ. Press
36. Holtgrave DR, Pinkerton SD. 1997. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J. AIDS Hum. Retrovirol. 16:54-62
37. Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D. 1998. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J. AIDS Hum. Retrovirol. 18(Suppl. 1):S133-38
38. Holtgrave DR, Pinkerton SD, Merson M. 2002. Estimating the cost of unmet HIV prevention needs in the United States. Am. J. Prev. Med. 23:7-12
39. Holtgrave DR, Qualls NL, Graham JD. 1996. Economic evaluation of HIV prevention programs. Annu. Rev. Public Health 17:467-88
40. Holtgrave DR, Thomas CW, Chen H, Edlavitch S, Pinkerton SD, Fleming P. 2000. HIV prevention community planning and communities of color: Do resources track the epidemic? AIDS Public Policy J. 15:75-81
41. Holtgrave DR, Valdiserri RO, West GA. 1994. Quantitative economic evaluations of HIV-related prevention and treatment services: a review. Risk 5:29-47
42. Inst. Med. 2001. No Time to Lose: Getting More from HIV Prevention. Washington, DC: Natl. Acad. Press
43. Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD, DeCock KM 2001. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am. J. Public Health 91:1019-24
44. Kahn JG. 1998. Economic evaluation of primary HIV prevention in injection drug users. See Ref. 31, pp. 45-62
45. Karon JM, Fleming PL, Steketee RW, DeCock KM. 2001. HIV in the United States at the turn of the century: an epidemic in transition. Am. J. Public Health 91:1060-68
46. Katz MH, Schwarcz SK, Kellogg TA, Klausner J, Dilley JW, et al. 2002. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men in San Francisco. Am. J. Public Health 91:388-94
47. Natl. Inst. Health. 1997. Interventions to prevent HIV risk behaviors. NIH Consens. Statement Online (1997 Feb. 11-13). 15(2):1-41
48. Pinkerton SD, Holtgrave DR, DiFranceisco WJ, Stevenson LY, Kelly JA. 1998. Cost-effectiveness of a community-level HIV risk reduction intervention. Am. J. Public Health 88:1239-42
49. Pinkerton SD, Holtgrave DR, Jemmott JB. 2000. Economic analysis of an HIV risk reduction intervention for male African American adolescents. J. AIDS 25:164-72
50. Pinkerton SD, Johnson-Masotti AP, Holtgrave DR, Farnham PG. 2001. Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV. AIDS 15:917-18
51. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. 2000. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N. Engl. J. Med. 342(13):921-29
52. Schwartlander B, Stover J, Walker N, Bollinger L, Gutierrez JP, et al. 2001. AIDS: resource needs for HIV/AIDS. Science 292:2434-36
53. Strathdee SA, Vlahov D. 2001. The effectiveness of needle exchange programs: a review of the science and policy. AID-Science 1(16) http://www.aidscience.org/Articles/aidscience013.asp
54. Valdiserri RO. 2003. CDC deputy chief says trend 'very worrisome,' U.S. far from goal to cut new infections by half. AIDS Alert 18(6):75-55
55. Valdiserri RO, Ogden LO, Janssen RS, Onorato I, Martin T. 2004. Aligning budget with U.S. national HIV prevention priorities. J. Public Health Manage. Pract. 10(2):140-47
56. Valdiserri RO, Ogden LL, McCray E. 2003. Accomplishments in HIV prevention science: implications for stemming the epidemic. Nat. Med. 9(7):881-86
57. Wolitski RJ, Janssen RS, Holtgrave DR, Peterson JL. 2003. The public health response to the HIV epidemic in the United States. In AIDS and Other Manifestations of HIV Infection, ed. G Wormser, pp. 983-99. San Diego: Academic. 4th ed.